US Patent Issued to PTC THERAPEUTICS on Nov. 4 for "Method for treating nonsense mutation mediated duchenne muscular dystrophy in pediatric patients" (New Jersey Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,629, issued on Nov. 4, was assigned to PTC THERAPEUTICS INC. (South Plainfield, N.J.).

"Method for treating nonsense mutation mediated duchenne muscular dystrophy in pediatric patients" was invented by Ronald Kong (River Edge, N.J.) and Joseph William McIntosh (Wyckoff, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein is a method for ameliorating or managing nonsense mutation mediated Duchenne muscular dystrophy (nmDMD) in a pediatric patient in need thereof comprising, administering an effective amount of ataluren to the patient."

The patent was filed on April 9, 2020, under Application No. 17/602,576.

*For further information, ...